Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Great post!!! Thanks Mav
!!!
Unfortunately/ this came out on the 22st and nothing since
Congrats!!!!
I think gempicker is right on target. Nicely patient here.
J
A R/S will damage the PPS immediately and then it will fall again. Nothing but bad news if it were to occur in my opinion.
If I follow your logic, Hill's current 30 million shares would become 12k (30mil divided by 2500 =. 12,000 ) shares x $1.05 or worth a total of $12,600.00. Did I follow your math correctly?
Why and how did you arrive at these numbers?
Btw, I apologize. You did say "JMO". I missed that. My bad.
Do you just make this stuff up as you go along? If so, admit it's a guess.
There are facts known and then there is BS being tossed about. Add to that, old unrelated data no longer useful in understanding the current situation that only serves to make this more confusing to those who don't know to ignore it.
IMO is a very useful acronym. We could take a lesson from Mav.
I won't make a list of the new important details that we know, but for those watching, this stock will not R/S for reasons previously discussed and is poised for a run, pull back, comsolidation, and the run again. That's MY OPINION.
I also think that if revenues pick up dramatically, an IND comes through, the PR cycle starts, we get the European Patent and Ray Hill takes the CEO position, we can completely ignore the A/S issue we are fond of discussing and we will go far beyond the .02 numbers we've discussed. I peg that change to rapid escalation to 0.25+
IMO
No....it's not. Thank you for playing.
Deep breath. It's not even close to over.
Would you restate that?
Yes..it was. Reposting old news never stopped some.
Thanks for this post!
Gem...as you know, most of us are waiting for much more that .001. ?? I made quite a bit scalping this early on during its downs and ups, then bought in & averaged down again at 0001. Now the upside potential is way too cool.
I made lots w Apple, but this is much more fun.
Completely 100% correct!
Entirely your opinion - to which you're entitled. It is, however, only an opinion.
In pinks, there is generally no technology or fundamentals to back up the stock...
Not everything here is a simile to other pinks.
Gannicus point was.., you can't read Bollies over 17 months. Period. Let's stick to current events. Thanks
Thanks for clarifying!
Yes, we did. Longs just choose to ignore the repetitive chants that the sky has fallen AND the earth caved in...all while we see neither has happened.
The PPS has fallen, but the technology remains & new blood at the door appears ready to lead the company. Finally. So, things will change
Correct. Exactly. I said something similar, but my post was thrown into the wind.
Things are changing.
33 million in volume so far this am. Looking forward...it's just a new game. That's all.
The prediction of change is where some people are clearly expert, where others are happy to just sit in chairs an point backward (in time). Gannicus is predicting the future.
This post incorrectly reflects the state of affairs in my opinion. The players have a major amount of skin in the game and, as I've said before, it makes more sense for them to keep pushing for a big dollar outcome than the small dollars that you discuss.
The investing public can make their own decision, but the movement here appears pretty obvious that SVFC isn't getting sloppy - they are becoming much more strategic. Good for longs, bad for shorts.
Imo.
You and me both Cano73!
Was this fact or fiction?
So many $$SVFC $$should $$be $$could $$be $$could Preferred Shares are NOT affected by any Reverse Split btw
$$Victor $$Anna $$BOD $$No $$Skin $$Involved $$Profits $$Out $$Shareholders $$Pockets $$Nice $$Racket
The investing public would be aided by a clearer understanding of the above.
FDA- this is the relevant url: http://www.fda.gov/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/CellularandGeneTherapy/ucm427692.htm#INTRO
We have to see what have to see how the FDA responds to intellicell's petition.
Why get shaken out at this point. That would be a ridiculous waste. Particularly when something is clearly getting ready to happen.
I have my call into Jim Hock as well.
It's very obvious to me that this is a plan ...250 billion as a number didn't fall from the sky. A finance deal is clearly coming.
Don't mislead the investing public. Make sure it's clear this is to the AS not to the OS...
Sigh
Jim Hock agrees with you. So do I.
Unlike that, I do know that you contacted them. Please do Contact Dr Andrews if you didn't And provide your own verified data regarding him.
Better yet, I'll call.
I have time on Monday if he has time. No guarantees, but doctor to doctor is sometimes easier than doctor to CPA (& I'm sure you had your ortho call him). I'll just try anyway and see what I can learn anyway.
I'll also call Jim Hock....while I watch the ask continue to thin.
Hang onto your cheap shares. It was a smart move.
Nope...thank you. You asked for a pr ...got it...don't like it...and now ?
May we move one?
Raymond Hill is on the board...until he is not.
Call him.
NEW YORK, NY--(Marketwired - Aug 21, 2014) - IntelliCell BioSciences, Inc. ("IntelliCell" or the "Company") (OTCQB: SVFC), a regenerative medicine company utilizing adult autologous stromal vascular cells (SVCs) derived from the blood vessels found in adipose tissue, announced today that it has added Mr. Raymond Hill to its Board of Directors.
Mr. Hill has held a number of senior executive roles in the pharmaceutical industry, including President of InVentiv Clinical, CEO and member of the Board of Directors of PPD, and President of IMS Consulting Group. Earlier on in his career, Mr. Hill was a partner at A.T. Kearney and a consultant at Booz Allen & Hamilton.
IntelliCell's Chief Executive Officer, Dr. Steven Victor, remarked, "This is a significant addition to the Board of Directors as Mr. Hill brings substantial experience in the field of FDA clinical trials. Mr. Hill is a valuable asset to the company, especially as IntelliCell is embarking on FDA IND clinical claim studies for Osteoarthritis with Dr. James Andrews as well as exploring clinical studies for Autism and ALS."
About IntelliCell Biosciences
IntelliCell is a pioneering regenerative medicine company focused on the expanding regenerative medical markets using adult autologous stromal vascular fraction cells (SVFCs) derived from the blood vessels in the adult adipose tissue. IntelliCell BioSciences has developed its own patented technology and protocol to separate adult autologous vascular cells from adipose tissue without the use of enzymes. IntelliCell is also developing technology-licensing agreements with technology developers, universities, and international business entities.
Forward-Looking Statements
Again...duck test. Even he says he's a member. Good lord, let it go. Enjoy your day!
Thanks for the great update!!
Just logged on to level 2... This is going to be fun!!
Ok...I'm sure you're right. We imagined that Ray Hill was on the Board. It was a grand illusion.
I stand by my statement. It passes the duck test.